Opinion takes from our editorial desk.
200 articles
This week’s bank earnings matter less as standalone reports than as a stress test for the entire soft-landing trade. Investors are asking the group to confirm resilient consumers, stable credit, decent loan demand and trading strength all at once — a burden that leaves little room for even a modest miss.
The latest semiconductor selloff looks more like a crowding reset than proof that AI demand is cracking. The money appears to be moving from the most obvious chip winners toward hyperscalers, networking, and custom silicon names just as earnings are about to test whether AI spending is broadening.
MongoDB’s 5.7% drop looks disconnected from what the business is actually doing. Atlas is still growing above 29%, AI retrieval just expanded beyond Atlas, and that makes this look more like a reset in sentiment than a break in the story.
CrowdStrike’s 5.7% drop looks far more like a multiple tantrum than evidence the business is slipping. The platform keeps widening across SIEM, browser, cloud, identity, and AI security, while growth and market leadership signals remain intact.
Meta’s latest AI chip milestone makes its spending spree look a lot more like platform building than unchecked capex. With September production now on the table, the market has a concrete reason to believe Meta is turning AI infrastructure into a durable edge.
Okta’s 6.9% drop looks disconnected from what the business is actually building. If AI agents become the next identity control point, OKTA has already moved from theme to product while the stock is still being priced like a slower-growth software name.
This is not a clean story of a healthy consumer, and it is not a retail-wide collapse either. The pressure is showing up in mix and margins, with essentials and value merchants still holding demand while discretionary names absorb the sharper earnings reset.
The bullish AI case does not have to fade for leadership to rotate. This week’s chip volatility, grid-strain headlines, and transformer shortages all point to the next leg of AI monetization moving toward electrical equipment, cooling, and grid capacity.
PepsiCo's post-earnings drop looks like a market fixated on one weak region while ignoring the part of the quarter that kept the broader story alive. International organic revenue growth, improving global volume, and unchanged full-year guidance matter more than a soft North America print.
TSMC looks like the market's next real AI stress test, and the setup still leans bullish into July 16. When a company is growing revenue 33% with 61.9% gross margins and Wall Street is pressing for higher 2026 expectations, the earnings bar is high for a reason.
Alnylam just got the kind of competitive win biotech investors rarely get handed this cleanly: a rival late-stage ATTR-CM miss after AMVUTTRA already secured the label and commercial traction. With revenue up 65.2% year over year and AMVUTTRA driving more than $1 billion in quarterly product revenue, the stock still looks like the clearest winner in a narrowing field.
Ionis got hit as if the Wainua trial miss broke the whole equity story, and that looks too simplistic. The bigger near-term driver is now TRYNGOLZA's expanded launch, with commercial revenue already up 42% and management raising its olezarsen peak-sales view above $3 billion.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator